Literature DB >> 24912183

Vaccinating captive chimpanzees to save wild chimpanzees.

Kelly L Warfield1, Jason E Goetzmann2, Julia E Biggins3, Mary Beth Kasda3, Robert C Unfer1, Hong Vu1, M Javad Aman1, Gene Gerrard Olinger3, Peter D Walsh4.   

Abstract

Infectious disease has only recently been recognized as a major threat to the survival of Endangered chimpanzees and Critically Endangered gorillas in the wild. One potentially powerful tool, vaccination, has not been deployed in fighting this disease threat, in good part because of fears about vaccine safety. Here we report on what is, to our knowledge, the first trial in which captive chimpanzees were used to test a vaccine intended for use on wild apes rather than humans. We tested a virus-like particle vaccine against Ebola virus, a leading source of death in wild gorillas and chimpanzees. The vaccine was safe and immunogenic. Captive trials of other vaccines and of methods for vaccine delivery hold great potential as weapons in the fight against wild ape extinction.

Entities:  

Keywords:  conservation; filovirus; wildlife disease

Mesh:

Substances:

Year:  2014        PMID: 24912183      PMCID: PMC4066532          DOI: 10.1073/pnas.1316902111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Catastrophic ape decline in western equatorial Africa.

Authors:  Peter D Walsh; Kate A Abernethy; Magdalena Bermejo; Rene Beyers; Pauwel De Wachter; Marc Ella Akou; Bas Huijbregts; Daniel Idiata Mambounga; Andre Kamdem Toham; Annelisa M Kilbourn; Sally A Lahm; Stefanie Latour; Fiona Maisels; Christian Mbina; Yves Mihindou; Sosthène Ndong Obiang; Ernestine Ntsame Effa; Malcolm P Starkey; Paul Telfer; Marc Thibault; Caroline E G Tutin; Lee J T White; David S Wilkie
Journal:  Nature       Date:  2003-04-06       Impact factor: 49.962

2.  Plaque assay for Ebola virus.

Authors:  J B Moe; R D Lambert; H W Lupton
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

3.  Development of a preventive vaccine for Ebola virus infection in primates.

Authors:  N J Sullivan; A Sanchez; P E Rollin; Z Y Yang; G J Nabel
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

4.  Analysis of Ebola virus and VLP release using an immunocapture assay.

Authors:  George Kallstrom; Kelly L Warfield; Dana L Swenson; Shannon Mort; Rekha G Panchal; Gordon Ruthel; Sina Bavari; M Javad Aman
Journal:  J Virol Methods       Date:  2005-04-25       Impact factor: 2.014

5.  Epitopes involved in antibody-mediated protection from Ebola virus.

Authors:  J A Wilson; M Hevey; R Bakken; S Guest; M Bray; A L Schmaljohn; M K Hart
Journal:  Science       Date:  2000-03-03       Impact factor: 47.728

6.  A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever.

Authors:  M Bray; K Davis; T Geisbert; C Schmaljohn; J Huggins
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

7.  Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.

Authors:  Gene Garrard Olinger; James Pettitt; Do Kim; Cara Working; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael Pauly; Kevin J Whaley; Calli M Lear; Julia E Biggins; Corinne Scully; Lisa Hensley; Larry Zeitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

8.  Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells.

Authors:  Jason D Marshall; Edith M Hessel; Josh Gregorio; Christina Abbate; Priscilla Yee; Mabel Chu; Gary Van Nest; Robert L Coffman; Karen L Fearon
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

9.  Anthrax kills wild chimpanzees in a tropical rainforest.

Authors:  Fabian H Leendertz; Heinz Ellerbrok; Christophe Boesch; Emmanuel Couacy-Hymann; Kerstin Mätz-Rensing; Regine Hakenbeck; Carina Bergmann; Pola Abaza; Sandra Junglen; Yasmin Moebius; Linda Vigilant; Pierre Formenty; Georg Pauli
Journal:  Nature       Date:  2004-07-22       Impact factor: 49.962

10.  Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management.

Authors:  S P Fisher-Hoch; G S Platt; G Lloyd; D I Simpson; G H Neild; A J Barrett
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

View more
  12 in total

1.  Ebola: The great ape gamble.

Authors:  Cassandra Willyard
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

Review 2.  Animal Models of Ebolavirus Infection.

Authors:  Marisa C St Claire; Dan R Ragland; Laura Bollinger; Peter B Jahrling
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

3.  A cytomegalovirus-based vaccine provides long-lasting protection against lethal Ebola virus challenge after a single dose.

Authors:  Yoshimi Tsuda; Christopher J Parkins; Patrizia Caposio; Friederike Feldmann; Sara Botto; Susan Ball; Ilhem Messaoudi; Luka Cicin-Sain; Heinz Feldmann; Michael A Jarvis
Journal:  Vaccine       Date:  2015-03-25       Impact factor: 3.641

Review 4.  From bench to almost bedside: the long road to a licensed Ebola virus vaccine.

Authors:  Gary Wong; Emelissa J Mendoza; Francis A Plummer; George F Gao; Gary P Kobinger; Xiangguo Qiu
Journal:  Expert Opin Biol Ther       Date:  2017-11-17       Impact factor: 4.388

5.  Destabilization of the gut microbiome marks the end-stage of simian immunodeficiency virus infection in wild chimpanzees.

Authors:  Hannah J Barbian; Yingying Li; Miguel Ramirez; Zachary Klase; Iddi Lipende; Deus Mjungu; Andrew H Moeller; Michael L Wilson; Anne E Pusey; Elizabeth V Lonsdorf; Frederic D Bushman; Beatrice H Hahn
Journal:  Am J Primatol       Date:  2015-12-16       Impact factor: 2.371

Review 6.  Ebola virus vaccines - reality or fiction?

Authors:  Chad E Mire; Thomas W Geisbert; Heinz Feldmann; Andrea Marzi
Journal:  Expert Rev Vaccines       Date:  2016-05-09       Impact factor: 5.217

Review 7.  Progress of vaccine and drug development for Ebola preparedness.

Authors:  Woo Young Choi; Kee-Jong Hong; Joo Eun Hong; Won-Ja Lee
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

8.  Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.

Authors:  Kelly L Warfield; John M Dye; Jay B Wells; Robert C Unfer; Frederick W Holtsberg; Sergey Shulenin; Hong Vu; Dana L Swenson; Sina Bavari; M Javad Aman
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

9.  Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.

Authors:  Hannah J Barbian; Julie M Decker; Frederic Bibollet-Ruche; Rachel P Galimidi; Anthony P West; Gerald H Learn; Nicholas F Parrish; Shilpa S Iyer; Yingying Li; Craig S Pace; Ruijiang Song; Yaoxing Huang; Thomas N Denny; Hugo Mouquet; Loic Martin; Priyamvada Acharya; Baoshan Zhang; Peter D Kwong; John R Mascola; C Theo Verrips; Nika M Strokappe; Lucy Rutten; Laura E McCoy; Robin A Weiss; Corrine S Brown; Raven Jackson; Guido Silvestri; Mark Connors; Dennis R Burton; George M Shaw; Michel C Nussenzweig; Pamela J Bjorkman; David D Ho; Michael Farzan; Beatrice H Hahn
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

10.  Ebola hemorrhagic Fever and the current state of vaccine development.

Authors:  Joo Eun Hong; Kee-Jong Hong; Woo Young Choi; Won-Ja Lee; Yeon Hwa Choi; Chung-Hyeon Jeong; Kwang-Il Cho
Journal:  Osong Public Health Res Perspect       Date:  2014-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.